SCHEMBL26548455

SCHEMBL26548455

C[Si](C)(C)c1ccc(-c2ccc(-c3ccc4cc(-c5ccc(-c6cccc7c6oc6ncccc67)cc5)ccc4c3)cc2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 10/20 0.35
PRKDC P78527 4/20 0.35
PIK3C2B O00750 3/20 0.35
PIK3R1 P27986 3/20 0.35
PIK3C2A O00443 2/20 0.35
PIK3C3 Q8NEB9 2/20 0.35
JAK1 P23458 2/20 0.34
TYK2 P29597 2/20 0.34
JAK2 O60674 1/20 0.34
JAK3 P52333 1/20 0.34
ALOX5 P09917 1/20 0.33
ABL1 P00519 2/20 0.33
NPC1 O15118 1/20 0.33
POLB P06746 1/20 0.33
RAB9A P51151 1/20 0.33
PIK3CD O00329 2/20 0.32
PIK3CB P42338 2/20 0.32
PIK3CG P48736 2/20 0.32
MTOR P42345 2/20 0.32
CHUK O15111 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26548078 1.00 PIK3CA (0.35) PIK3CAPRKDCPIK3C2BPIK3R1PIK3C2A
SCHEMBL26548627 0.96 PIK3CA (0.34) PIK3CAPRKDCPIK3C2BPIK3R1PIK3C2A
SCHEMBL26548952 0.96 PIK3CA (0.34) PIK3CAPRKDCPIK3C2BPIK3R1PIK3C2A
SCHEMBL26549125 0.90 GAK (0.37) PIK3CAPRKDCPIK3C2BPIK3R1PIK3C2A
SCHEMBL26549410 0.90 GAK (0.37) PIK3CAPRKDCPIK3C2BPIK3R1PIK3C2A
SCHEMBL26564297 0.89 COMT (0.40) PIK3CAPRKDCPIK3C2BPIK3R1PIK3C2A
SCHEMBL26548272 0.89 PIK3CA (0.34) PIK3CAPRKDCPIK3C2BPIK3R1PIK3C2A
SCHEMBL26552631 0.88 PIK3CA (0.40) PIK3CAPRKDCPIK3C2BPIK3R1PIK3C2A
SCHEMBL26548448 0.86 TOP1 (0.40) PIK3CAPRKDCPIK3C2BPIK3R1PIK3C2A
SCHEMBL26551092 0.86 PIK3CA (0.35) PIK3CAPRKDCPIK3C2BPIK3R1PIK3C2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230337527-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME LAPTO CO., LTD. (KR) 2023-10-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230337527-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME AOC1, ODC1, PIEZO1 PIK3CA 4826/4885PRKDC 2422/4885PIK3C2B 4558/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.